Toggle navigation
Home
Search
Services
Blog
Contact
About
Cancer Chemoprevention by Sulfur Compounds
Lam, Luke K.
Lkt Laboratories, Inc., St. Paul, MN, United States
Search 18 grants from Luke Lam
Search grants from Lkt Laboratories, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Developing an Automated Image Analysis and Finite Element Modeling Platform to Assess the Effects of Supplemental Protein and Weight Loss on Bone Health in Obese Older Adults
Molecular regulation of HIV-1 assembly, release and cell-to-cell transmission
INIA: Genetic Analysis of Alcohol Consumption and Stress
Adaptor Proteins and Malignant Transformation
Mathematical Sciences: Rigidity Phenomena in Differential Geometry and Dynamical Systems
Recently added grants:
C-di-AMP signaling in S. aureus
Mediators of fatty liver disease during HIV/SIV and cART treatment
The Role of the RIP Kinases in Coordinating Neuroinflammation and Host Defense
Regulation of Allergen-Induced Airway Pathophysiology by Versican
Kinetics, evolution, and effector function of Fc repertoires during vaccination with native-like Env trimers
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44CA062707-02A1
Application #
2008445
Study Section
Special Emphasis Panel (ZRG3-SSS-Z (02))
Project Start
1994-08-01
Project End
1998-03-30
Budget Start
1996-09-30
Budget End
1997-04-30
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Lkt Laboratories, Inc.
Department
Type
DUNS #
City
St. Paul
State
MN
Country
United States
Zip Code
55114
Related projects
NIH 1997
R44 CA
Cancer Chemoprevention by Sulfur Compounds
Lam, Luke K. / Lkt Laboratories, Inc.
NIH 1996
R44 CA
Cancer Chemoprevention by Sulfur Compounds
Lam, Luke K. / Lkt Laboratories, Inc.
Comments
Be the first to comment on this grant